cirm.ca.gov2d
Matrices macroporosas inyectables para mejorar el injerto y la supervivencia de células madre
A pesar de lo prometedoras que son las células madre para la medicina regenerativa, la eficacia de las terapias basadas en células madre está muy limitada por un deficiente injerto y supervivencia de ...
cirm.ca.gov4d
Reprogramming Somatic Cells into iPSCs Engineered with an Anti-PSCA CAR to Develop Allogeneic Off-the-Shelf Cell Therapy to Treat Pancreatic Cancer
Our candidate product PSCA-CAR_s15 uiNK is derived from transduction of iPSCs selected from the most ideal source and episomally reprogrammed from mature NK cells or CD34+ cells. Our goal is to ...